Switching from originator recombinant growth hormone (Genotropin™) to biosimilar (CRISCY™): Results from a 6-month, multicentric, non-inferiority, extension trial.
Czepielewski MA, Garret Q, Vencio SAC, Rassi N, Faria MS, Senn CCP, Bronstein MD, Cerqueira MJAG, Neves ACL, Spinola-Castro AM, Cunha MPR, Leite NR, Wassermann GE, Alegria MC, Toffoletto O, Afiune J, Baradelli R, Rodrigues DG, Scharf M.
Czepielewski MA, et al. Among authors: leite nr.
Growth Horm IGF Res. 2021 Feb;56:101372. doi: 10.1016/j.ghir.2020.101372. Epub 2020 Nov 28.
Growth Horm IGF Res. 2021.
PMID: 33260063
Clinical Trial.